Quarterly report pursuant to Section 13 or 15(d)

Note 13 - Subsequent Events

v3.20.2
Note 13 - Subsequent Events
3 Months Ended
Sep. 30, 2020
Notes to Financial Statements  
Subsequent Events [Text Block]

Note 13. Subsequent Events:

On October 20, 2020, the Company acquired 47.6% of the outstanding equity shares of Changzhou Eminence Biotechnology Co., Ltd. for approximately $10 million.